ArticleJournal of medical case reports2026
Chronic arsenic poisoning from a realgar-containing traditional medicine causing hepatic veno-occlusive disease and polyserositis: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatic veno-occlusive disease (VOD) is a potentially life-threatening vascular liver disorder. Its association with chronic arsenic poisoning from traditional medicines is rare, and this case highlights a unique etiology and the importance of timely intervention. CASE PRESENTATION: A 20-year-old Han Chinese female presented with progressive abdominal distension after self-administering Jian'er Pills (containing realgar, As₂S₂) at 15 tablets/day for one year-25% above the recommended maximum dose. Clinical, laboratory, imaging, and histopathological data were collected. Physical examination revealed palmoplantar hyperkeratosis, diffuse hyperpigmentation, hepatomegaly, and ascites. No peripheral edema was noted. Laboratory tests confirmed severe arsenic toxicity (urinary arsenic 4523.6 μg/L; blood arsenic 151.4 μg/L) and pancytopenia. Liver function tests showed ALT 78 U/L, AST 65 U/L, total bilirubin 1.2 mg/dL, direct bilirubin 0.4 mg/dL. Imaging showed hepatomegaly with periportal edema, massive ascites, and bilateral pleural and pericardial effusions. Liver biopsy confirmed VOD with characteristic features: sinusoidal dilatation, central venule obliteration, and hyaline microthrombi. The patient received chelation therapy with sodium dimercaptopropanesulfonate and sodium thiosulfate. Within four days, pericardial and pleural effusions resolved completely, and ascites volume decreased by > 50%. After three treatment cycles, all effusions resolved and hepatic venous flow normalized. At 7-month follow-up, arsenic levels normalized, with no recurrence of effusions and normal liver function.
conclusionsChronic excessive intake of arsenic-containing traditional medicines can precipitate life-threatening VOD with polyserositis. Early diagnosis and prompt chelation therapy are crucial for achieving complete and sustained recovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.